Show simple item record

dc.contributor.authorDe la Cruz Ku, G.
dc.contributor.authorAizpuru, M.
dc.contributor.authorHackl, H.
dc.contributor.authorUbl, D.S.
dc.contributor.authorHabermann, E.B.
dc.contributor.authorPery, R.
dc.contributor.authorDriedger, M.
dc.contributor.authorAssinger, A.
dc.contributor.authorNagorney, D.M.
dc.contributor.authorCleary, S.P.
dc.contributor.authorSmoot, R.L.
dc.contributor.authorStarlinger, P.
dc.date.accessioned2025-10-31T18:34:43Z
dc.date.available2025-10-31T18:34:43Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5176
dc.description.abstractBackground: Experimental evidence suggests sex dependent differences in liver regeneration. Limited evidence is available examining sex differences in post-hepatectomy liver failure (PHLF) and postoperative outcomes. Our aim was to assess the influence of sex on the outcomes after liver resection. Methods: The hepatectomy targeted National Surgical Quality Improvement Program (NSQIP) database was assessed for associations between sex and outcomes. Results: A total of 13,401 patients underwent elective hepatic resection between 2014-2017. PHLF was highest among male patients with hepatocellular carcinoma (HCC) (OR = 2.81,95%CI:1.40–5.62). Male sex was independently associated with increased PHLF (OR = 1.47,95%CI:1.15–1.88), major complications (OR = 1.25,95%CI:1.08–1.45), mortality (OR = 1.61,95%CI:1.03–2.50), and if only major resections were assessed (OR = 1.38,95%CI:1.03–1.84). Diagnosis specific subgroup analyses revealed that effects of sex were predominantly HCC associated. Conclusions: This is the largest series investigating the effects of gender on outcomes after hepatic resection. We documented that women undergoing liver resection have significantly lower risk of PHLF. This difference seemed influenced by the striking increase of PHLF in male HCC patients. These hypothesis suggest that sex might play a role in preoperative risk stratification.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:1365-182X
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectHepatocellular Carcinoma Managementen_US
dc.subjectPortal Vein Embolization in Liver Surgeryen_US
dc.titleHepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortalityen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1016/j.hpb.2022.02.009
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.21
dc.type.otherResearch article
dc.identifier.journalHPB
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2